| Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis TJ Parmenter, M Kleinschmidt, KM Kinross, ST Bond, J Li, MR Kaadige, ... Cancer discovery 4 (4), 423-433, 2014 | 311 | 2014 |
| Host immunity contributes to the anti-melanoma activity of BRAF inhibitors DA Knight, SF Ngiow, M Li, T Parmenter, S Mok, A Cass, NM Haynes, ... The Journal of clinical investigation 123 (3), 1371-1381, 2013 | 291 | 2013 |
| The combination of epigallocatechin gallate and curcumin suppresses ERα‐breast cancer cell growth in vitro and in vivo TJ Somers‐Edgar, MJ Scandlyn, EC Stuart, MJ Le Nedelec, SP Valentine, ... International journal of cancer 122 (9), 1966-1971, 2008 | 162 | 2008 |
| Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin B Yadav, S Taurin, RJ Rosengren, M Schumacher, M Diederich, ... Bioorganic & medicinal chemistry 18 (18), 6701-6707, 2010 | 130 | 2010 |
| A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells AJ Butt, CG Roberts, AA Seawright, PB Oelrichs, JK MacLeod, TYE Liaw, ... Molecular cancer therapeutics 5 (9), 2300-2309, 2006 | 111 | 2006 |
| A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate MJ Scandlyn, EC Stuart, TJ Somers-Edgar, AR Menzies, RJ Rosengren British journal of cancer 99 (7), 1056-1063, 2008 | 107 | 2008 |
| Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines TJ Somers-Edgar, S Taurin, L Larsen, A Chandramouli, MA Nelson, ... Investigational new drugs 29, 87-97, 2011 | 82 | 2011 |
| Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells TJ Somers-Edgar, RJ Rosengren Anti-Cancer Drugs 20 (1), 33-40, 2009 | 33 | 2009 |
| Deer velvet supplementation decreases the grade and metastasis of azoxymethane-induced colon cancer in the male rat A Fraser, SR Haines, EC Stuart, MJ Scandlyn, A Alexander, ... Food and chemical toxicology 48 (5), 1288-1292, 2010 | 31 | 2010 |
| Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma LK Smith, T Parmenter, M Kleinschmidt, EP Kusnadi, J Kang, CA Martin, ... Nature Communications 13 (1), 1100, 2022 | 16 | 2022 |
| Host immunity contributes to the anti-melanoma activity of BRAF inhibitors DA Knight, SF Ngiow, M Li, T Parmenter, S Mok, A Cass, NM Haynes, ... The Journal of Clinical Investigation 126 (1), 402-403, 2016 | 14 | 2016 |
| Genome-wide RNAi screen for genes regulating glycolytic response to vemurafenib in BRAFV600 melanoma cells LK Smith, T Parmenter, CM Gould, PB Madhamshettiwar, KE Sheppard, ... Scientific Data 7 (1), 339, 2020 | 1 | 2020 |
| RNA binding kinase UHMK1 regulates therapy induced metabolic adaptation in BRAFV600 melanoma LK Smith, T Parmenter, M Kleinschmidt, EP Kusnadi, J Kang, CA Martin, ... bioRxiv, 626952, 2019 | 1 | 2019 |
| Erratum: Host immunity contributes to the anti-melanoma activity of BRAF inhibitors (The Journal of clinical investigation PII: e177489) DA Knight, SF Ngiow, M Li, T Parmenter, S Mok, A Cass, NM Haynes, ... The Journal of clinical investigation 133 (24), 2023 | | 2023 |
| Host immunity contributes to the anti-melanoma activity of BRAF inhibitors DA Knight, SF Ngiow, M Li, T Parmenter, S Mok, A Cass, NM Haynes, ... Journal of Clinical Investigation 133 (24), e177489, 2023 | | 2023 |
| Sweet rebellion: a campaign for a sugar-sweetened beverage tax in New Zealand T Parmenter, C Jordan, I Jayasinghe The New Zealand Medical Journal (Online) 130 (1461), 78, 2017 | | 2017 |
| Mutant NRAS regulates glycolysis in melanoma through ERK, mTOR and the MYC/HIF1 alpha/MondoA network of transcriptional regulators AD Rao, LK Smith, TJ Parmenter, GA McArthur MOLECULAR CANCER RESEARCH 14, 2016 | | 2016 |
| Abstract B23: Mutant NRAS regulates glycolysis in melanoma through ERK, mTOR and the MYC/HIF1α/MondoA network of transcriptional regulators AD Rao, LK Smith, TJ Parmenter, GA McArthur Molecular Cancer Research 14 (1_Supplement), B23-B23, 2016 | | 2016 |
| A novel mitochondrial inhibitor overcomes metabolic reprogramming and enhances the response of NRAS-mutant melanoma cells to MEK inhibition A Rao, L Smith, T Parmenter, J Schreuders, T Butt, T Tiganis, C Culllinane, ... European Journal of Cancer 1 (69), S23, 2016 | | 2016 |
| CHARACTERISING GLUCOSE METABOLISM AS A POTENTIAL THERAPEUTIC TARGET IN NRAS-MUTANT MELANOMA AD Rao, TJ Parmenter, L Smith, GA McArthur ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 10, 45-45, 2014 | | 2014 |
